Therapeutic siRNA targeting PLIN2 ameliorates steatosis, inflammation, and fibrosis in steatotic liver disease models
Yao Wang1, Jiaxin Zhou1, Qi Yang1, Xinmeng Li2, Yifu Qiu3,2 , Yansong Zhang1,4,*, Min Liu1,3,*, and Alan Jian Zhu1,3,4,*
北京大學(xué)生命科學(xué)學(xué)院劉敏研究員、朱健教授、張延松博士
1 Ministry of Education Key Laboratory of Cell Proliferation and Differentiation, School of Life Sciences, Peking University, Beijing, China
2 Institute of Molecular Medicine, Beijing Key Laboratory of Cardiometabolic Molecular Medicine, College of Future Technology, Peking University, Beijing, China
3 Peking-Tsinghua Center for Life Sciences, Academy for Advanced Interdisciplinary Studies, Peking University, Beijing, China
4 Peking University Chengdu Academy for Advanced Interdisciplinary Biotechnologies, Chengdu, Sichuan, China
